$LEGN  Legend burst on the scene a few years ago with impressive clinical trial results in treating relapsed multiple myeloma patients with JNJ-4528, and the data keeps getting better. $JNJ

At a median follow-up time of 11.5 months, 86% of patients were in complete remission.